{"ticker": {"uuid": "0a0022b7-ef77-41d0-a07c-06be62b4e72d", "symbol": "ENOV", "name": "Enovis Corp", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Enovis Corp (ENOV) Shares Surge 3.8% -- What GF Score of 60 Tells Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQbnFkbHVXdE11Szdqb1lSOFF3M0dwWjhIT3Nsb1VwS1pVanFGQzFJVEtzNV9LX0lkcnF6aUJmNkZTZExSaVlfanBJN3lnWWNCNkVhTjVROXJwTXFlaG1aWEFObkM1bms4dHlyWUhjV2xFRzBpckoteTRwS0NpM0xCcFhKOXA4WGtseEVGdEhoVDZwOTdtaTdGN2VXTUJMTUQ4aC1NTGd5LUYwZmFuYUQ2c2JBRWoxbk5RWUgw?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-16T00:57:48+00:00", "published_display": "16 Jul 2026 00:57", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Enovis (ENOV) Stock Trades Up, Here Is Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPVm94d1lBenNrQjVfZlFKRF9GOEFpOWxSUmM5ZWFwYmhTQVlhVENSdXRqTEJDRlpreTlJUnJaVEpFdFY1V0JxZUNiMk9Qb1FrYjB0cGYtUDYyb0kwOTFjaGtjNGJUa2lGeXpaVk1tY0xJckM1amwxVXJET1o0TGhVbTJFYVpCbm1tZGV3LTdOOFlyV2pQNmtXMA?oc=5", "source_name": "Market source", "published_at": "2026-07-13T22:38:39+00:00", "published_display": "13 Jul 2026 22:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis\u2122 Companion Animal Health Launches CT-RevitL\u2122, the Next-Generation Laser Therapy System for Veterinary Care", "summary": "Enovis's Companion Animal Health business has launched CT-RevitL\u2122, a new veterinary laser therapy system, in the U.S. This next-generation system aims to deliver deeper, faster, and more consistent therapeutic outcomes for animals, built on extensive research in photobiomodulatio", "url": "https://www.globenewswire.com/news-release/2026/07/13/3326176/0/en/enovis-companion-animal-health-launches-ct-revitl-the-next-generation-laser-therapy-system-for-veterinary-care.html", "source_name": "GlobeNewswire", "published_at": "2026-07-13T16:11:45", "published_display": "13 Jul 2026 16:11", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis Launches New Veterinary Laser Therapy System in the U.S.", "summary": "Enovis Corporation has launched CT-RevitL\u2122, a new veterinary PBM laser therapy system in the U.S., through its Companion Animal Health business. This system aims to provide enhanced clinical performance, greater mobility, and a more intuitive treatment experience for veterinary t", "url": "https://www.myvetcandy.com/news/2026/7/13/enovis-launches-new-veterinary-laser-therapy-system-in-the-us", "source_name": "Vet Candy", "published_at": "2026-07-13T13:42:07", "published_display": "13 Jul 2026 13:42", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis launches veterinary laser therapy system in U.S.", "summary": "Enovis Corporation launched CT-RevitL, a new veterinary laser therapy system, in the U.S. This system uses photobiomodulation to manage pain, accelerate healing, and reduce inflammation in animals. The launch includes a clinical education program, and the company plans for intern", "url": "https://www.investing.com/news/company-news/enovis-launches-veterinary-laser-therapy-system-in-us-93CH-4788513", "source_name": "Investing.com", "published_at": "2026-07-13T13:40:19", "published_display": "13 Jul 2026 13:40", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New CT-RevitL laser aims to speed pain relief and healing for pets", "summary": "Enovis' Companion Animal Health has launched CT-RevitL, a new veterinary photobiomodulation (PBM) laser therapy system in the U.S. This system is designed to provide deeper, faster, and more consistent therapeutic outcomes for animals, leveraging over 150 published PBM studies an", "url": "https://www.stocktitan.net/news/ENOV/enovis-tm-companion-animal-health-launches-ct-revit-ltm-the-next-2qozeuexppv0.html", "source_name": "Stock Titan", "published_at": "2026-07-13T12:40:19", "published_display": "13 Jul 2026 12:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Enovis (ENOV) Leaving Russell Defensive Indexes Signal A Deeper Shift In Its Risk Profile?", "summary": "Enovis Corporation (NYSE: ENOV) was removed from the Russell 2000 Value-Defensive and Defensive Indexes on June 27, 2026, indicating a potential shift in its risk and style classification within the small-cap universe. This exclusion prompts a reevaluation of the company's invest", "url": "https://simplywall.st/stocks/us/healthcare/nyse-enov/enovis/news/does-enovis-enov-leaving-russell-defensive-indexes-signal-a", "source_name": "Simply Wall Street", "published_at": "2026-07-09T15:40:19", "published_display": "09 Jul 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BMO Capital Initiates Enovis at Outperform With $29 Price Target", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/bmo-capital-initiates-enovis-outperform-122427607.html", "source_name": "MT Newswires", "published_at": "2026-07-09T12:24:27+00:00", "published_display": "09 Jul 2026 12:24", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "American Century affiliates report 10.6% holdings in Enovis (ENOV)", "summary": "American Century Investment Management, Inc. and American Century Companies, Inc. have reported a 10.6% beneficial ownership stake in Enovis Corporation (ENOV) through an amended SCHEDULE 13G/A filing. Separately, American Century Capital Portfolios, Inc. holds 4.7% of Enovis com", "url": "https://www.stocktitan.net/sec-filings/ENOV/schedule-13g-a-enovis-corp-amended-passive-investment-disclosure-77fe2049c4e1.html", "source_name": "Stock Titan", "published_at": "2026-07-08T14:39:22", "published_display": "08 Jul 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis (ENOV) Following CMS Reversal, Why The Valuation Story Is Back In Focus", "summary": "Enovis (ENOV) has experienced a sharp stock price increase following the Centers for Medicare & Medicaid Services' reversal of planned reimbursement cuts for its noninvasive bone growth stimulators. Despite years of weak shareholder returns, this regulatory decision has put the c", "url": "https://simplywall.st/stocks/us/healthcare/nyse-enov/enovis/news/enovis-enov-following-cms-reversal-why-the-valuation-story-i/amp", "source_name": "Simply Wall Street", "published_at": "2026-07-07T23:09:43", "published_display": "07 Jul 2026 23:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Enovis (ENOV) Stock Is Trading Up Today", "summary": "Shares of medical technology company Enovis Corporation (ENOV) surged 15% after the Centers for Medicare & Medicaid Services reversed previously announced reimbursement cuts for the company's non-invasive bone growth stimulators. This decision, coupled with broader strength in th", "url": "https://www.theglobeandmail.com/investing/markets/stocks/ENOV/pressreleases/3148476/why-enovis-enov-stock-is-trading-up-today/", "source_name": "The Globe and Mail", "published_at": "2026-07-07T02:20:28", "published_display": "07 Jul 2026 02:20", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore Maintains Enovis Corp(ENOV.US) With Buy Rating, Cuts Target Price to $32", "summary": "Evercore has reiterated its Buy rating on Enovis Corp (ENOV.US) but has reduced the target price for the stock to $32. The revision indicates the firm's continued positive outlook on the company despite potential adjustments to its valuation.", "url": "https://www.moomoo.com/news/post/72526744/evercore-maintains-enovis-corp-enovus-with-buy-rating-cuts-target", "source_name": "Moomoo", "published_at": "2026-07-06T15:40:19", "published_display": "06 Jul 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis shares jump after Medicare reverses reimbursement cuts", "summary": "Enovis Corp shares rose approximately 11% following Medicare's reversal of previously announced reimbursement cuts for the company\u2019s non-invasive bone growth stimulators. The decision by the Centers for Medicare & Medicaid Services positively impacted the company's stock. This ar", "url": "https://www.investing.com/news/stock-market-news/enovis-shares-jump-after-medicare-reverses-reimbursement-cuts-93CH-4776971", "source_name": "Investing.com", "published_at": "2026-07-06T15:09:00", "published_display": "06 Jul 2026 15:09", "sentiment": "positive", "sentiment_pct": 93, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BTIG Maintains Enovis Corp(ENOV.US) With Buy Rating, Maintains Target Price $39", "summary": "BTIG has reiterated its Buy rating for Enovis Corp (ENOV.US) and maintained a target price of $39. This indicates that BTIG continues to have a positive outlook on the company's stock performance.", "url": "https://www.moomoo.com/news/post/72520818/btig-maintains-enovis-corp-enovus-with-buy-rating-maintains-target", "source_name": "Moomoo", "published_at": "2026-07-06T14:40:19", "published_display": "06 Jul 2026 14:40", "sentiment": "positive", "sentiment_pct": 76, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis (ENOV) director Christine Ortiz receives 846-share stock award", "summary": "Enovis (ENOV) director Christine Ortiz was granted 846 shares of common stock on June 30, 2026, as a compensation-related award with a stated price of $0.00 per share. This transaction increased her direct holdings to 25,857 shares of Enovis common stock. The Form 4 filing indica", "url": "https://www.stocktitan.net/sec-filings/ENOV/form-4-enovis-corp-insider-trading-activity-50b6911058ca.html", "source_name": "Stock Titan", "published_at": "2026-07-02T01:40:03", "published_display": "02 Jul 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Enovis Corp For: 1 July By Investing.com", "summary": "This article from Investing.com UK is a Form 4 filing for Enovis Corp, dated July 1st. It provides a brief mention of the company (ENOV) and its stock performance (+12.28%), alongside extensive financial market data and news headlines. The content primarily focuses on market move", "url": "https://uk.investing.com/news/stock-market-news/form-4-enovis-corp-for-1-july-93CH-4754147", "source_name": "Investing.com UK", "published_at": "2026-07-02T01:09:56", "published_display": "02 Jul 2026 01:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors Are Reacting To Enovis (ENOV) Russell 2000 Defensive Index Removal And Rebalancing", "summary": "Enovis Corporation (NYSE: ENOV) was removed from the Russell 2000 Defensive and Value-Defensive Indices on June 27, 2026, which may lead to short-term trading volatility as index-tracking funds rebalance. The article notes that this removal does not change Enovis's core strategy ", "url": "https://simplywall.st/stocks/us/healthcare/nyse-enov/enovis/news/how-investors-are-reacting-to-enovis-enov-russell-2000-defen", "source_name": "Simply Wall Street", "published_at": "2026-07-02T00:13:36", "published_display": "02 Jul 2026 00:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis stock hits 52-week low at 20.45 USD", "summary": "Enovis Corporation's stock has fallen to a 52-week low of $20.45, representing a 37.1% decrease over the past year and placing it 44% below its 52-week high. Despite this decline, InvestingPro analysts suggest the stock is undervalued, predicting future profitability and setting ", "url": "https://www.investing.com/news/company-news/enovis-stock-hits-52week-low-at-2045-usd-93CH-4768138", "source_name": "Investing.com", "published_at": "2026-06-30T15:09:40", "published_display": "30 Jun 2026 15:09", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis (ENOV) Could Be 46% Undervalued As Net Profit Jumps 84%", "summary": "Enovis (ENOV) recently reported an 84.34% year-over-year increase in net profit on quarterly revenue of US$589.15 million, suggesting it could be significantly undervalued by 46% according to certain models, trading at US$22.71 against a fair value of US$42.30. Despite a weak yea", "url": "https://simplywall.st/stocks/us/healthcare/nyse-enov/enovis/news/enovis-enov-could-be-46-undervalued-as-net-profit-jumps-84", "source_name": "Simply Wall Street", "published_at": "2026-06-27T14:42:43", "published_display": "27 Jun 2026 14:42", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Enovis Corporation \u2013 NYSE:ENOV", "summary": "This article provides a brief financial snippet for Enovis Corporation (NYSE: ENOV), displaying its enterprise value to revenue forward. It indicates the period, value, and change percentages for this financial metric. The content is presented by TradingView and includes standard", "url": "https://www.tradingview.com/symbols/NYSE-ENOV/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T00:10:51", "published_display": "27 Jun 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh", "summary": "This page provides financial actuals and estimates for Enovis Corporation (E2NO34) on the BMFBOVESPA exchange. It allows users to explore reported financial data and analyst estimates across various financial statements and valuation metrics. Users can compare actual results with", "url": "https://www.tradingview.com/symbols/BMFBOVESPA-E2NO34/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T16:09:24", "published_display": "26 Jun 2026 16:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Enovis Corporation \u2013 NYSE:ENOV", "summary": "The article focuses on the enterprise value to EBITDA forward for Enovis Corporation (NYSE: ENOV). It appears to be a financial data snippet from TradingView, providing a period, value, and change for this specific financial metric. The content is presented within the context of ", "url": "https://www.tradingview.com/symbols/NYSE-ENOV/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T13:09:24", "published_display": "26 Jun 2026 13:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Enovis Corporation \u2013 NYSE:ENOV", "summary": "The article displays the \"Price to earnings forward\" metric for Enovis Corporation (NYSE: ENOV). It shows that for the displayed period, the value was 'No trades', indicating no recent trading activity for this specific financial metric. The content is primarily a data point pres", "url": "https://www.tradingview.com/symbols/NYSE-ENOV/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T03:41:21", "published_display": "26 Jun 2026 03:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh Actuals & Estimates (BMFBOVESPA:E2NO34)", "summary": "This article provides an overview of Enovis Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh (E2NO34) on the BMFBOVESPA exchange, focusing on its financial actuals and estimates. It highlights that users can explore reported financial data and analyst estimat", "url": "https://www.tradingview.com/symbols/BMFBOVESPA-E2NO34/forecast-actuals-and-estimates/?category=balance_sheet", "source_name": "TradingView", "published_at": "2026-06-26T00:41:21", "published_display": "26 Jun 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ENOV - Enovis Corp Short Interest", "summary": "This article provides a detailed financial overview of Enovis Corp (ENOV), including its last closing price, market capitalization, income, sales, and various financial ratios. It also highlights short interest data, insider and institutional ownership, and stock performance over", "url": "https://finviz.com/stock?t=ENOV&ty=si&p=d", "source_name": "Finviz", "published_at": "2026-06-25T11:10:35", "published_display": "25 Jun 2026 11:10", "sentiment": "negative", "sentiment_pct": 37, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis Corp (ENOV) Financial Health: Profitability & Balance Sheet Analysis", "summary": "Enovis Corp (ENOV) has a current financial score of 6.28, placing it 164th out of 204 in the Healthcare Equipment & Supplies industry, indicating weak financial status but average operating efficiency. The company recently reported a quarterly revenue of $589.15M, a 5.43% year-ov", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-enov/financial-health", "source_name": "TradingKey", "published_at": "2026-06-24T09:11:01", "published_display": "24 Jun 2026 09:11", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis Corp (ENOV) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Enovis Corp (ENOV), detailing its current price momentum score, support and resistance levels. It reviews various technical indicators like MACD, RSI, and moving averages, all of which currently suggest a \"Sell\" signal for the stock. ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-enov/technical", "source_name": "TradingKey", "published_at": "2026-06-24T05:09:42", "published_display": "24 Jun 2026 05:09", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ENOV Technical Analysis & Stock Price Forecast", "summary": "This article provides a technical analysis and stock price forecast for Enovis Corp (ENOV), indicating a \"Strong Sell\" consensus based on various technical indicators and moving averages. The analysis highlights key support and resistance levels, momentum indicators like RSI and ", "url": "https://intellectia.ai/en/stock/ENOV/technical", "source_name": "Intellectia AI", "published_at": "2026-06-23T02:40:03", "published_display": "23 Jun 2026 02:40", "sentiment": "negative", "sentiment_pct": 26, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis (ENOV) CAO adds 1,000 shares in $20.92 open-market buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQZ2p1YmFvdVBtSEswZXJILTVmb1JMVk5wejM0V2VFMzNpTUFjRlA3V2ROTE1nR2dZWnVRNjdCLXRTWjVTMTFRSEVGSWtmOHBMSWNnOWtnR3U0MHM3R1BPOXRkczg1QllFSkRTMl9HRDhvSGhZNWhvNzdDM1VZdEEwZWdYaW1mYnIyQ09YQnRBcGo0ZklBa0pFUzVzOTg3bEg3dERJTENfLS0?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Enovis (ENOV) CAO Oliver Engert adds 1,200 shares in open-market buys", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOUlhWVUJHc183RTQ3OFNxM1V4NW1paldjeElaclI3bF9adUx6Q1VZMjRGcGJNQmxtNFhNSW5kamlrbUU5NGZvU1AtRVJyZkt6NUp6THUyd3dFS1FnYmZ2b25IdndYY2J3VmVTdXZNZmt2U3lKM3pPYTNOdTlVZFlXanZqcEJ2emhlN1J6ZzFibWlJS1hQUTJfX3BLYzdMdUNNQ3o5UlBjNVA?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CD&R Engages Former Enovis CEO as Operating Advisor", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/cd-r-engages-former-enovis-110000203.html", "source_name": "PR Newswire", "published_at": "2026-06-11T11:00:00+00:00", "published_display": "11 Jun 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Enovis (NYSE:ENOV) And Medical Devices & Supplies - Specialty Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQRWNsVUM3aGV5UmJHYUowOWtNRU11RzZSalpyampRQ3ZQTlBNV05zSHo4MTJJS0JqTV92LWV3MUdXWkRIckNNZi1aeVg1TmtKNFpoS3g5dTBXRW1BZXRMWGo1SVl2NjNaQ2NSNV90V0MtMzBEQndVclZzUUVXbi1FU0lyU0FndlAwaXNfUVpOTXBEZWQtQVpmanRoU0JjLWxlakFJSQ?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Enovis (ENOV) Valuation After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPQ2h1Y0dzUFdBTmhzTG8xNnZLcWRScWhET2Vnb1RodGk0QmV6UGVJdUY0MjVrMUo4WkRidk1JR191eVdQaW0wU1VhWmpndTRqd1BBZUhEY1NyYzF0SXh3VjNRVklicXoyZ2ttSEJnTmVoeTJxdThxZ1VDWTR5dUJXXy1sYnFJU3lTbV9nQVFIcmc0bzltdWduVjlBWW9kclRZQ0dZaEhR?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis stock hits 52-week low at 20.79 USD", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOaWJGVlVOeDFIZmJFQ2ZwMEhUN1lDNjVhM0JtNHBIRXlkaHpSVTFJZXZiSzRMakZpQVA1anQ0bFc2WVFKSHlLVlUwZ2l5NmdIUUlwWVEwbWF4NGpwcFhrZ3k2cWFHWDlaU294MkJ0ZW5QSjh3cVoxanhEM0JLVkZoRnZkc3pXRFhpVDZHeS13OTBaaUtzOVRDTW56M0R0Zw?oc=5", "source_name": "Investing.com", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Enovis Corporation (ENOV) a High-Growth, Under-Valued Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPQ20yUERaMWVicW5zVC1pRHkyenYxYXE0NUNUOGp0LU9LNExDTHc5NE95TFI1Ny1pRGNZRHNRV2RNbkV4elVXOUFjU2tyT0hNcXlGb19PaWNsNDlhS20zRWNLdktZaXpHNF9Pa2J2YjR0czcweV9rbmc0RHJ2YjdqZnFFUUluQlJQcURmNUk1ajBNcFlkOHl2Z0pKY1dqMjJDOVE?oc=5", "source_name": "Market source", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis Launches Spinamic\u00ae Hybrid Scoliosis Brace, Combining", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgJBVV95cUxNR2loLVRTZnVpZTZzOUtZRV9LQ0c4M3NkbVJkTExTYTRmTHAwWkhIWlZoemZvZDc3Rm1KUVcxYlJpV01FVkVyUV9JZGFwcENSbENkYWMwWmR1dmduVmZieGtmMGZTNmVHaWRQMFNMeF94Z0JxeFFsVDFWMUhMTEtEdm9kS0FKSUpCQjFGVHhON2dIMmdrSjVNUjlEcERyclV4aXdMTzNUUFFBRUg2bzNDRUhDWVk3ODktWnFWYTBhZVA2SmFTRlNLaW1QYUlWNTNUSnplTklVN2hWZE1OUldKQ1dlMkxhZW1SX3pZLURYMUE2SGpGbnBnUFdraTJab2tyRjE1UTdJTFVwYXpmMlZCNnk4UzZjN3cyS3BHMFUwRkdSRHExalE?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Investment Story For Enovis (ENOV) Is Evolving Without New Analyst Targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPbUh5WkUwY0tRVWVWeWNMbDhYUmpTX19YY1NMeXVDVlZZT3JfY0hKUnJwekFsNVh2dHJBMjFXZUZFUS0talZ5ZnBDcktscXM5cDN3R3M2Y3RGQjFmN0c4TVQ3VGpwTGNVRGRhcGdTVXluNkFLZlp4VTlBYTZHcEtjZlBqWnZYaWc4X0JmXy1DYlFiaWtUckJJU1JobmxLbWNEZkcwdA?oc=5", "source_name": "Market source", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis (ENOV): Revenue Beat, Margins Expand and Full-Year Outlook Maintained", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNU3p1ajk2M1BKaXhOcEpqdS1WSjVOUk1LOE1FUGxsMDZueUxxOE9GS09xNFhoMGsxNFF1QjVud1BfSHB1Q0c3X3dTTjV6Rl9RWjNtOFFLWkV3UmpXLUJoZGNLa3hORDY5XzJUQVdwV1BsdjBvMTlONDN5RVVjSVNZLVg4U25yVS13dmlWSE5raFFNdmR1eEhXMnNzbEpXQQ?oc=5", "source_name": "Market source", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis (ENOV) Chief Administrative Officer buys 1,000 shares in open market", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOUDF1b09aNjNNZjVXaUdvdW0tS3Q3VGxidExCSTRJMW1HYWlia1RlTUFLQzZaVzNXUXJyMktGcTc1V3lNU3QxNHVmb3I3NzBRMkpEM012cm5qSF9DVlJPVDVEaHM4dWtnSEJEU20wcmpUYnpTdWdBaGljamtjNmltQ1VmbVRxUW1YN0xDSDdnUmw5V09WWEJ4eVhzUi1GV3FlQWo2QnBLcWE?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Small-Cap Stock Picks: Hims & Hers Buy, Enovis & LifeStance Sell | May 2026 - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxNTDc0SGJQblFqdENtdU5YR05IUlZ0SGJ6VFVFUF8xQmtJTHRQSjBGNVliYVc2cWI3Y1lJbUstelgzeFNVU2daQmZ0Zk1XQnphNVJTZTc0R3VnNDc2RlVURHpsdE1qV3dzM0JlNklCZjRFaFhUSFpzZmNQeTBkcU01Vk82ZEtUcFdGYWNUeTNVdEFQUQ?oc=5", "source_name": "IndexBox", "published_at": "2026-05-19T02:40:00+00:00", "published_display": "19 May 2026 02:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is There Now An Opportunity In Enovis (ENOV) After Multi Year Share Price Slump", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is Enovis (ENOV) Stock Rocketing Higher Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNTjJNM1hLSVNndlpZVW55UG5XUm1QVVM1ZEZvdzFmZ1o0THdXMWhBOV9KRUlwQzFPZjRPWXhSZWJGY2pBMjJGakhmR25mNlNwZTU0RmRUaDdfeWFnc0NlQUhUSFJJbGJBVzYxUjM5ZS01MWlPRFVNbzBFY2xTeFg5QlYwLTVWQk1CTUZxaDVSQ0ludWJlNUt2UzVucUtmWTZWWm1rOVFpY3JNb2s?oc=5", "source_name": "StockStory", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis (NYSE:ENOV) Exceeds Q1 CY2026 Expectations", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOOUYxcGJkc3o0M3VzSy1ab0I1d2VuX1RydUg1MUJHT2ZPMG5GbVNOVThpekZvX3N6UGRzQlpCcHAwRlNPOXZOVi1NTlRFeXlnbUxIdlNIRGVFTFZ0WjlEOGxPc29wWnNzQ25MZUszbk1QWl9TSUJSYWQ2MUhXSks3T0VvU2FmOE5xUlQ4Z0xMOWhtSWg5SDVwS2dPbzU?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Did William Blair\u2019s FCF-Focused ENOV Call Just Shift Enovis\u2019 Investment Narrative?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQelVFV3BTS2tESlRoS25mR21vMWkzaWJGcXhmcFhQNGM2OTl3WFlMTFpUOEVUUkVfdVlROVRaYllxRHVLSjREQzZldmZrNDdEWWx6ZnNXcV9RMlFOdThzb2J0ck4zNG0tbE12MldYbkZTZ1NqM29RNGtSdzNGTGl0RS1UbU9vMW9tdkY5ZmRBckhzQWpNdXV5RVVR?oc=5", "source_name": "Market source", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "William Blair Assigns Outperform Rating to Enovis (ENOV)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNRXJzSE8yNDZ0TkxEUHhFNjFoU2d3bGVJNmtoY2JCckNGMnJ2ZlRKdDQ3cE0tM2RPNHh5RnY0alZSdnpDekFBdXkyT0ZJZ0dtQmxqdC1LV0w4dFA1S3ZsUTRwaE9CdzlKMXV2cmZsWTFVTVFfdzNIYW8tWl9CZVFPLWdicUQxdC1HN0h0cEdfdjNUSkNXWU5XMjBFNUtkQTVFYjhvMWJJZw?oc=5", "source_name": "Market source", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Enovis Weighs US$501.3m Impairment Against Nebula Led Organic Growth", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-28T08:00:00+00:00", "published_display": "28 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis: Valuation Is Too Low, But Needs To Differentiate On Growth (NYSE:ENOV)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOODAyZFlKeXgxcFZ4elRyNmZpZUUtcjdqbnkwTC1JTi1kNE9PeVBxeG8zWmMxNGx6MGNjODJLRWdaTGd2OFNBSHFoNEVqalE1Q1R6ckh6dkR5cjBFNmpMeUJqVEJaYldaWUlUV25YWHVLc0sxMUtuVkVEbVpXMGFvMW40YkgzOC1rNHVsTHRDQk45T2YyTU13WU5uR0RJYk1xajFUV2txWU4?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis Corporation Reports 7% Sales Growth in Q2 2025, Driven by 11% Increase in Reconstructive Sales", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxPcVZZRjgwT2xiU1EyWUVieDR0bGptSHQ3MGRlYVdPTksyV0tWNHBNUUhYdVBSdk1Da1RHUEJycGpLZnp5OFQtS2Y4bUxIV3hlV0hPcWFDSVRWeGdqbTY4WW1UT0RVMGp3ZHdSVEV4RGpKODNtOHhqQVhNV3pOMmlIU25LWW1hNFVJa3UzcDVOUUZDcHZEN0c0YWRaTzVTLVIzQ2J3TlRxRmsyTHlNOEM4N1pTUUFNa1R6OE5xcEQ1N3RWR1o3ZENZQWNOcmdnUG93MnJocVI1Yw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2025-08-07T07:00:00+00:00", "published_display": "07 Aug 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Enovis Corp (ENOV) Shares Surge 3.8% -- What GF Score of 60 Tells Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQbnFkbHVXdE11Szdqb1lSOFF3M0dwWjhIT3Nsb1VwS1pVanFGQzFJVEtzNV9LX0lkcnF6aUJmNkZTZExSaVlfanBJN3lnWWNCNkVhTjVROXJwTXFlaG1aWEFObkM1bms4dHlyWUhjV2xFRzBpckoteTRwS0NpM0xCcFhKOXA4WGtseEVGdEhoVDZwOTdtaTdGN2VXTUJMTUQ4aC1NTGd5LUYwZmFuYUQ2c2JBRWoxbk5RWUgw?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-16T00:57:48+00:00", "published_display": "16 Jul 2026 00:57", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis (ENOV) Stock Trades Up, Here Is Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPVm94d1lBenNrQjVfZlFKRF9GOEFpOWxSUmM5ZWFwYmhTQVlhVENSdXRqTEJDRlpreTlJUnJaVEpFdFY1V0JxZUNiMk9Qb1FrYjB0cGYtUDYyb0kwOTFjaGtjNGJUa2lGeXpaVk1tY0xJckM1amwxVXJET1o0TGhVbTJFYVpCbm1tZGV3LTdOOFlyV2pQNmtXMA?oc=5", "source_name": "Market source", "published_at": "2026-07-13T22:38:39+00:00", "published_display": "13 Jul 2026 22:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis\u2122 Companion Animal Health Launches CT-RevitL\u2122, the Next-Generation Laser Therapy System for Veterinary Care", "summary": "Enovis's Companion Animal Health business has launched CT-RevitL\u2122, a new veterinary laser therapy system, in the U.S. This next-generation system aims to deliver deeper, faster, and more consistent therapeutic outcomes for animals, built on extensive research in photobiomodulatio", "url": "https://www.globenewswire.com/news-release/2026/07/13/3326176/0/en/enovis-companion-animal-health-launches-ct-revitl-the-next-generation-laser-therapy-system-for-veterinary-care.html", "source_name": "GlobeNewswire", "published_at": "2026-07-13T16:11:45", "published_display": "13 Jul 2026 16:11", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis Launches New Veterinary Laser Therapy System in the U.S.", "summary": "Enovis Corporation has launched CT-RevitL\u2122, a new veterinary PBM laser therapy system in the U.S., through its Companion Animal Health business. This system aims to provide enhanced clinical performance, greater mobility, and a more intuitive treatment experience for veterinary t", "url": "https://www.myvetcandy.com/news/2026/7/13/enovis-launches-new-veterinary-laser-therapy-system-in-the-us", "source_name": "Vet Candy", "published_at": "2026-07-13T13:42:07", "published_display": "13 Jul 2026 13:42", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis launches veterinary laser therapy system in U.S.", "summary": "Enovis Corporation launched CT-RevitL, a new veterinary laser therapy system, in the U.S. This system uses photobiomodulation to manage pain, accelerate healing, and reduce inflammation in animals. The launch includes a clinical education program, and the company plans for intern", "url": "https://www.investing.com/news/company-news/enovis-launches-veterinary-laser-therapy-system-in-us-93CH-4788513", "source_name": "Investing.com", "published_at": "2026-07-13T13:40:19", "published_display": "13 Jul 2026 13:40", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New CT-RevitL laser aims to speed pain relief and healing for pets", "summary": "Enovis' Companion Animal Health has launched CT-RevitL, a new veterinary photobiomodulation (PBM) laser therapy system in the U.S. This system is designed to provide deeper, faster, and more consistent therapeutic outcomes for animals, leveraging over 150 published PBM studies an", "url": "https://www.stocktitan.net/news/ENOV/enovis-tm-companion-animal-health-launches-ct-revit-ltm-the-next-2qozeuexppv0.html", "source_name": "Stock Titan", "published_at": "2026-07-13T12:40:19", "published_display": "13 Jul 2026 12:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Enovis (ENOV) Leaving Russell Defensive Indexes Signal A Deeper Shift In Its Risk Profile?", "summary": "Enovis Corporation (NYSE: ENOV) was removed from the Russell 2000 Value-Defensive and Defensive Indexes on June 27, 2026, indicating a potential shift in its risk and style classification within the small-cap universe. This exclusion prompts a reevaluation of the company's invest", "url": "https://simplywall.st/stocks/us/healthcare/nyse-enov/enovis/news/does-enovis-enov-leaving-russell-defensive-indexes-signal-a", "source_name": "Simply Wall Street", "published_at": "2026-07-09T15:40:19", "published_display": "09 Jul 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BMO Capital Initiates Enovis at Outperform With $29 Price Target", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/bmo-capital-initiates-enovis-outperform-122427607.html", "source_name": "MT Newswires", "published_at": "2026-07-09T12:24:27+00:00", "published_display": "09 Jul 2026 12:24", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "American Century affiliates report 10.6% holdings in Enovis (ENOV)", "summary": "American Century Investment Management, Inc. and American Century Companies, Inc. have reported a 10.6% beneficial ownership stake in Enovis Corporation (ENOV) through an amended SCHEDULE 13G/A filing. Separately, American Century Capital Portfolios, Inc. holds 4.7% of Enovis com", "url": "https://www.stocktitan.net/sec-filings/ENOV/schedule-13g-a-enovis-corp-amended-passive-investment-disclosure-77fe2049c4e1.html", "source_name": "Stock Titan", "published_at": "2026-07-08T14:39:22", "published_display": "08 Jul 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis (ENOV) Following CMS Reversal, Why The Valuation Story Is Back In Focus", "summary": "Enovis (ENOV) has experienced a sharp stock price increase following the Centers for Medicare & Medicaid Services' reversal of planned reimbursement cuts for its noninvasive bone growth stimulators. Despite years of weak shareholder returns, this regulatory decision has put the c", "url": "https://simplywall.st/stocks/us/healthcare/nyse-enov/enovis/news/enovis-enov-following-cms-reversal-why-the-valuation-story-i/amp", "source_name": "Simply Wall Street", "published_at": "2026-07-07T23:09:43", "published_display": "07 Jul 2026 23:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Enovis (ENOV) Stock Is Trading Up Today", "summary": "Shares of medical technology company Enovis Corporation (ENOV) surged 15% after the Centers for Medicare & Medicaid Services reversed previously announced reimbursement cuts for the company's non-invasive bone growth stimulators. This decision, coupled with broader strength in th", "url": "https://www.theglobeandmail.com/investing/markets/stocks/ENOV/pressreleases/3148476/why-enovis-enov-stock-is-trading-up-today/", "source_name": "The Globe and Mail", "published_at": "2026-07-07T02:20:28", "published_display": "07 Jul 2026 02:20", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore Maintains Enovis Corp(ENOV.US) With Buy Rating, Cuts Target Price to $32", "summary": "Evercore has reiterated its Buy rating on Enovis Corp (ENOV.US) but has reduced the target price for the stock to $32. The revision indicates the firm's continued positive outlook on the company despite potential adjustments to its valuation.", "url": "https://www.moomoo.com/news/post/72526744/evercore-maintains-enovis-corp-enovus-with-buy-rating-cuts-target", "source_name": "Moomoo", "published_at": "2026-07-06T15:40:19", "published_display": "06 Jul 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis shares jump after Medicare reverses reimbursement cuts", "summary": "Enovis Corp shares rose approximately 11% following Medicare's reversal of previously announced reimbursement cuts for the company\u2019s non-invasive bone growth stimulators. The decision by the Centers for Medicare & Medicaid Services positively impacted the company's stock. This ar", "url": "https://www.investing.com/news/stock-market-news/enovis-shares-jump-after-medicare-reverses-reimbursement-cuts-93CH-4776971", "source_name": "Investing.com", "published_at": "2026-07-06T15:09:00", "published_display": "06 Jul 2026 15:09", "sentiment": "positive", "sentiment_pct": 93, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BTIG Maintains Enovis Corp(ENOV.US) With Buy Rating, Maintains Target Price $39", "summary": "BTIG has reiterated its Buy rating for Enovis Corp (ENOV.US) and maintained a target price of $39. This indicates that BTIG continues to have a positive outlook on the company's stock performance.", "url": "https://www.moomoo.com/news/post/72520818/btig-maintains-enovis-corp-enovus-with-buy-rating-maintains-target", "source_name": "Moomoo", "published_at": "2026-07-06T14:40:19", "published_display": "06 Jul 2026 14:40", "sentiment": "positive", "sentiment_pct": 76, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis (ENOV) director Christine Ortiz receives 846-share stock award", "summary": "Enovis (ENOV) director Christine Ortiz was granted 846 shares of common stock on June 30, 2026, as a compensation-related award with a stated price of $0.00 per share. This transaction increased her direct holdings to 25,857 shares of Enovis common stock. The Form 4 filing indica", "url": "https://www.stocktitan.net/sec-filings/ENOV/form-4-enovis-corp-insider-trading-activity-50b6911058ca.html", "source_name": "Stock Titan", "published_at": "2026-07-02T01:40:03", "published_display": "02 Jul 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Enovis Corp For: 1 July By Investing.com", "summary": "This article from Investing.com UK is a Form 4 filing for Enovis Corp, dated July 1st. It provides a brief mention of the company (ENOV) and its stock performance (+12.28%), alongside extensive financial market data and news headlines. The content primarily focuses on market move", "url": "https://uk.investing.com/news/stock-market-news/form-4-enovis-corp-for-1-july-93CH-4754147", "source_name": "Investing.com UK", "published_at": "2026-07-02T01:09:56", "published_display": "02 Jul 2026 01:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors Are Reacting To Enovis (ENOV) Russell 2000 Defensive Index Removal And Rebalancing", "summary": "Enovis Corporation (NYSE: ENOV) was removed from the Russell 2000 Defensive and Value-Defensive Indices on June 27, 2026, which may lead to short-term trading volatility as index-tracking funds rebalance. The article notes that this removal does not change Enovis's core strategy ", "url": "https://simplywall.st/stocks/us/healthcare/nyse-enov/enovis/news/how-investors-are-reacting-to-enovis-enov-russell-2000-defen", "source_name": "Simply Wall Street", "published_at": "2026-07-02T00:13:36", "published_display": "02 Jul 2026 00:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis stock hits 52-week low at 20.45 USD", "summary": "Enovis Corporation's stock has fallen to a 52-week low of $20.45, representing a 37.1% decrease over the past year and placing it 44% below its 52-week high. Despite this decline, InvestingPro analysts suggest the stock is undervalued, predicting future profitability and setting ", "url": "https://www.investing.com/news/company-news/enovis-stock-hits-52week-low-at-2045-usd-93CH-4768138", "source_name": "Investing.com", "published_at": "2026-06-30T15:09:40", "published_display": "30 Jun 2026 15:09", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis (ENOV) Could Be 46% Undervalued As Net Profit Jumps 84%", "summary": "Enovis (ENOV) recently reported an 84.34% year-over-year increase in net profit on quarterly revenue of US$589.15 million, suggesting it could be significantly undervalued by 46% according to certain models, trading at US$22.71 against a fair value of US$42.30. Despite a weak yea", "url": "https://simplywall.st/stocks/us/healthcare/nyse-enov/enovis/news/enovis-enov-could-be-46-undervalued-as-net-profit-jumps-84", "source_name": "Simply Wall Street", "published_at": "2026-06-27T14:42:43", "published_display": "27 Jun 2026 14:42", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Enovis Corporation \u2013 NYSE:ENOV", "summary": "This article provides a brief financial snippet for Enovis Corporation (NYSE: ENOV), displaying its enterprise value to revenue forward. It indicates the period, value, and change percentages for this financial metric. The content is presented by TradingView and includes standard", "url": "https://www.tradingview.com/symbols/NYSE-ENOV/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T00:10:51", "published_display": "27 Jun 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh", "summary": "This page provides financial actuals and estimates for Enovis Corporation (E2NO34) on the BMFBOVESPA exchange. It allows users to explore reported financial data and analyst estimates across various financial statements and valuation metrics. Users can compare actual results with", "url": "https://www.tradingview.com/symbols/BMFBOVESPA-E2NO34/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T16:09:24", "published_display": "26 Jun 2026 16:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Enovis Corporation \u2013 NYSE:ENOV", "summary": "The article focuses on the enterprise value to EBITDA forward for Enovis Corporation (NYSE: ENOV). It appears to be a financial data snippet from TradingView, providing a period, value, and change for this specific financial metric. The content is presented within the context of ", "url": "https://www.tradingview.com/symbols/NYSE-ENOV/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T13:09:24", "published_display": "26 Jun 2026 13:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Enovis Corporation \u2013 NYSE:ENOV", "summary": "The article displays the \"Price to earnings forward\" metric for Enovis Corporation (NYSE: ENOV). It shows that for the displayed period, the value was 'No trades', indicating no recent trading activity for this specific financial metric. The content is primarily a data point pres", "url": "https://www.tradingview.com/symbols/NYSE-ENOV/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T03:41:21", "published_display": "26 Jun 2026 03:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh Actuals & Estimates (BMFBOVESPA:E2NO34)", "summary": "This article provides an overview of Enovis Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh (E2NO34) on the BMFBOVESPA exchange, focusing on its financial actuals and estimates. It highlights that users can explore reported financial data and analyst estimat", "url": "https://www.tradingview.com/symbols/BMFBOVESPA-E2NO34/forecast-actuals-and-estimates/?category=balance_sheet", "source_name": "TradingView", "published_at": "2026-06-26T00:41:21", "published_display": "26 Jun 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ENOV - Enovis Corp Short Interest", "summary": "This article provides a detailed financial overview of Enovis Corp (ENOV), including its last closing price, market capitalization, income, sales, and various financial ratios. It also highlights short interest data, insider and institutional ownership, and stock performance over", "url": "https://finviz.com/stock?t=ENOV&ty=si&p=d", "source_name": "Finviz", "published_at": "2026-06-25T11:10:35", "published_display": "25 Jun 2026 11:10", "sentiment": "negative", "sentiment_pct": 37, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis Corp (ENOV) Financial Health: Profitability & Balance Sheet Analysis", "summary": "Enovis Corp (ENOV) has a current financial score of 6.28, placing it 164th out of 204 in the Healthcare Equipment & Supplies industry, indicating weak financial status but average operating efficiency. The company recently reported a quarterly revenue of $589.15M, a 5.43% year-ov", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-enov/financial-health", "source_name": "TradingKey", "published_at": "2026-06-24T09:11:01", "published_display": "24 Jun 2026 09:11", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis Corp (ENOV) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Enovis Corp (ENOV), detailing its current price momentum score, support and resistance levels. It reviews various technical indicators like MACD, RSI, and moving averages, all of which currently suggest a \"Sell\" signal for the stock. ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-enov/technical", "source_name": "TradingKey", "published_at": "2026-06-24T05:09:42", "published_display": "24 Jun 2026 05:09", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ENOV Technical Analysis & Stock Price Forecast", "summary": "This article provides a technical analysis and stock price forecast for Enovis Corp (ENOV), indicating a \"Strong Sell\" consensus based on various technical indicators and moving averages. The analysis highlights key support and resistance levels, momentum indicators like RSI and ", "url": "https://intellectia.ai/en/stock/ENOV/technical", "source_name": "Intellectia AI", "published_at": "2026-06-23T02:40:03", "published_display": "23 Jun 2026 02:40", "sentiment": "negative", "sentiment_pct": 26, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis (ENOV) CAO adds 1,000 shares in $20.92 open-market buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQZ2p1YmFvdVBtSEswZXJILTVmb1JMVk5wejM0V2VFMzNpTUFjRlA3V2ROTE1nR2dZWnVRNjdCLXRTWjVTMTFRSEVGSWtmOHBMSWNnOWtnR3U0MHM3R1BPOXRkczg1QllFSkRTMl9HRDhvSGhZNWhvNzdDM1VZdEEwZWdYaW1mYnIyQ09YQnRBcGo0ZklBa0pFUzVzOTg3bEg3dERJTENfLS0?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis (ENOV) CAO Oliver Engert adds 1,200 shares in open-market buys", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOUlhWVUJHc183RTQ3OFNxM1V4NW1paldjeElaclI3bF9adUx6Q1VZMjRGcGJNQmxtNFhNSW5kamlrbUU5NGZvU1AtRVJyZkt6NUp6THUyd3dFS1FnYmZ2b25IdndYY2J3VmVTdXZNZmt2U3lKM3pPYTNOdTlVZFlXanZqcEJ2emhlN1J6ZzFibWlJS1hQUTJfX3BLYzdMdUNNQ3o5UlBjNVA?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CD&R Engages Former Enovis CEO as Operating Advisor", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/cd-r-engages-former-enovis-110000203.html", "source_name": "PR Newswire", "published_at": "2026-06-11T11:00:00+00:00", "published_display": "11 Jun 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Enovis (NYSE:ENOV) And Medical Devices & Supplies - Specialty Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQRWNsVUM3aGV5UmJHYUowOWtNRU11RzZSalpyampRQ3ZQTlBNV05zSHo4MTJJS0JqTV92LWV3MUdXWkRIckNNZi1aeVg1TmtKNFpoS3g5dTBXRW1BZXRMWGo1SVl2NjNaQ2NSNV90V0MtMzBEQndVclZzUUVXbi1FU0lyU0FndlAwaXNfUVpOTXBEZWQtQVpmanRoU0JjLWxlakFJSQ?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Enovis (ENOV) Valuation After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPQ2h1Y0dzUFdBTmhzTG8xNnZLcWRScWhET2Vnb1RodGk0QmV6UGVJdUY0MjVrMUo4WkRidk1JR191eVdQaW0wU1VhWmpndTRqd1BBZUhEY1NyYzF0SXh3VjNRVklicXoyZ2ttSEJnTmVoeTJxdThxZ1VDWTR5dUJXXy1sYnFJU3lTbV9nQVFIcmc0bzltdWduVjlBWW9kclRZQ0dZaEhR?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis stock hits 52-week low at 20.79 USD", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOaWJGVlVOeDFIZmJFQ2ZwMEhUN1lDNjVhM0JtNHBIRXlkaHpSVTFJZXZiSzRMakZpQVA1anQ0bFc2WVFKSHlLVlUwZ2l5NmdIUUlwWVEwbWF4NGpwcFhrZ3k2cWFHWDlaU294MkJ0ZW5QSjh3cVoxanhEM0JLVkZoRnZkc3pXRFhpVDZHeS13OTBaaUtzOVRDTW56M0R0Zw?oc=5", "source_name": "Investing.com", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Enovis Corporation (ENOV) a High-Growth, Under-Valued Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPQ20yUERaMWVicW5zVC1pRHkyenYxYXE0NUNUOGp0LU9LNExDTHc5NE95TFI1Ny1pRGNZRHNRV2RNbkV4elVXOUFjU2tyT0hNcXlGb19PaWNsNDlhS20zRWNLdktZaXpHNF9Pa2J2YjR0czcweV9rbmc0RHJ2YjdqZnFFUUluQlJQcURmNUk1ajBNcFlkOHl2Z0pKY1dqMjJDOVE?oc=5", "source_name": "Market source", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis Launches Spinamic\u00ae Hybrid Scoliosis Brace, Combining", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgJBVV95cUxNR2loLVRTZnVpZTZzOUtZRV9LQ0c4M3NkbVJkTExTYTRmTHAwWkhIWlZoemZvZDc3Rm1KUVcxYlJpV01FVkVyUV9JZGFwcENSbENkYWMwWmR1dmduVmZieGtmMGZTNmVHaWRQMFNMeF94Z0JxeFFsVDFWMUhMTEtEdm9kS0FKSUpCQjFGVHhON2dIMmdrSjVNUjlEcERyclV4aXdMTzNUUFFBRUg2bzNDRUhDWVk3ODktWnFWYTBhZVA2SmFTRlNLaW1QYUlWNTNUSnplTklVN2hWZE1OUldKQ1dlMkxhZW1SX3pZLURYMUE2SGpGbnBnUFdraTJab2tyRjE1UTdJTFVwYXpmMlZCNnk4UzZjN3cyS3BHMFUwRkdSRHExalE?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Investment Story For Enovis (ENOV) Is Evolving Without New Analyst Targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPbUh5WkUwY0tRVWVWeWNMbDhYUmpTX19YY1NMeXVDVlZZT3JfY0hKUnJwekFsNVh2dHJBMjFXZUZFUS0talZ5ZnBDcktscXM5cDN3R3M2Y3RGQjFmN0c4TVQ3VGpwTGNVRGRhcGdTVXluNkFLZlp4VTlBYTZHcEtjZlBqWnZYaWc4X0JmXy1DYlFiaWtUckJJU1JobmxLbWNEZkcwdA?oc=5", "source_name": "Market source", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis (ENOV): Revenue Beat, Margins Expand and Full-Year Outlook Maintained", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNU3p1ajk2M1BKaXhOcEpqdS1WSjVOUk1LOE1FUGxsMDZueUxxOE9GS09xNFhoMGsxNFF1QjVud1BfSHB1Q0c3X3dTTjV6Rl9RWjNtOFFLWkV3UmpXLUJoZGNLa3hORDY5XzJUQVdwV1BsdjBvMTlONDN5RVVjSVNZLVg4U25yVS13dmlWSE5raFFNdmR1eEhXMnNzbEpXQQ?oc=5", "source_name": "Market source", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis (ENOV) Chief Administrative Officer buys 1,000 shares in open market", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOUDF1b09aNjNNZjVXaUdvdW0tS3Q3VGxidExCSTRJMW1HYWlia1RlTUFLQzZaVzNXUXJyMktGcTc1V3lNU3QxNHVmb3I3NzBRMkpEM012cm5qSF9DVlJPVDVEaHM4dWtnSEJEU20wcmpUYnpTdWdBaGljamtjNmltQ1VmbVRxUW1YN0xDSDdnUmw5V09WWEJ4eVhzUi1GV3FlQWo2QnBLcWE?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Small-Cap Stock Picks: Hims & Hers Buy, Enovis & LifeStance Sell | May 2026 - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxNTDc0SGJQblFqdENtdU5YR05IUlZ0SGJ6VFVFUF8xQmtJTHRQSjBGNVliYVc2cWI3Y1lJbUstelgzeFNVU2daQmZ0Zk1XQnphNVJTZTc0R3VnNDc2RlVURHpsdE1qV3dzM0JlNklCZjRFaFhUSFpzZmNQeTBkcU01Vk82ZEtUcFdGYWNUeTNVdEFQUQ?oc=5", "source_name": "IndexBox", "published_at": "2026-05-19T02:40:00+00:00", "published_display": "19 May 2026 02:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is There Now An Opportunity In Enovis (ENOV) After Multi Year Share Price Slump", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is Enovis (ENOV) Stock Rocketing Higher Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNTjJNM1hLSVNndlpZVW55UG5XUm1QVVM1ZEZvdzFmZ1o0THdXMWhBOV9KRUlwQzFPZjRPWXhSZWJGY2pBMjJGakhmR25mNlNwZTU0RmRUaDdfeWFnc0NlQUhUSFJJbGJBVzYxUjM5ZS01MWlPRFVNbzBFY2xTeFg5QlYwLTVWQk1CTUZxaDVSQ0ludWJlNUt2UzVucUtmWTZWWm1rOVFpY3JNb2s?oc=5", "source_name": "StockStory", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis (NYSE:ENOV) Exceeds Q1 CY2026 Expectations", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOOUYxcGJkc3o0M3VzSy1ab0I1d2VuX1RydUg1MUJHT2ZPMG5GbVNOVThpekZvX3N6UGRzQlpCcHAwRlNPOXZOVi1NTlRFeXlnbUxIdlNIRGVFTFZ0WjlEOGxPc29wWnNzQ25MZUszbk1QWl9TSUJSYWQ2MUhXSks3T0VvU2FmOE5xUlQ4Z0xMOWhtSWg5SDVwS2dPbzU?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Did William Blair\u2019s FCF-Focused ENOV Call Just Shift Enovis\u2019 Investment Narrative?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQelVFV3BTS2tESlRoS25mR21vMWkzaWJGcXhmcFhQNGM2OTl3WFlMTFpUOEVUUkVfdVlROVRaYllxRHVLSjREQzZldmZrNDdEWWx6ZnNXcV9RMlFOdThzb2J0ck4zNG0tbE12MldYbkZTZ1NqM29RNGtSdzNGTGl0RS1UbU9vMW9tdkY5ZmRBckhzQWpNdXV5RVVR?oc=5", "source_name": "Market source", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "William Blair Assigns Outperform Rating to Enovis (ENOV)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNRXJzSE8yNDZ0TkxEUHhFNjFoU2d3bGVJNmtoY2JCckNGMnJ2ZlRKdDQ3cE0tM2RPNHh5RnY0alZSdnpDekFBdXkyT0ZJZ0dtQmxqdC1LV0w4dFA1S3ZsUTRwaE9CdzlKMXV2cmZsWTFVTVFfdzNIYW8tWl9CZVFPLWdicUQxdC1HN0h0cEdfdjNUSkNXWU5XMjBFNUtkQTVFYjhvMWJJZw?oc=5", "source_name": "Market source", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis Weighs US$501.3m Impairment Against Nebula Led Organic Growth", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-28T08:00:00+00:00", "published_display": "28 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis: Valuation Is Too Low, But Needs To Differentiate On Growth (NYSE:ENOV)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOODAyZFlKeXgxcFZ4elRyNmZpZUUtcjdqbnkwTC1JTi1kNE9PeVBxeG8zWmMxNGx6MGNjODJLRWdaTGd2OFNBSHFoNEVqalE1Q1R6ckh6dkR5cjBFNmpMeUJqVEJaYldaWUlUV25YWHVLc0sxMUtuVkVEbVpXMGFvMW40YkgzOC1rNHVsTHRDQk45T2YyTU13WU5uR0RJYk1xajFUV2txWU4?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enovis Corporation Reports 7% Sales Growth in Q2 2025, Driven by 11% Increase in Reconstructive Sales", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxPcVZZRjgwT2xiU1EyWUVieDR0bGptSHQ3MGRlYVdPTksyV0tWNHBNUUhYdVBSdk1Da1RHUEJycGpLZnp5OFQtS2Y4bUxIV3hlV0hPcWFDSVRWeGdqbTY4WW1UT0RVMGp3ZHdSVEV4RGpKODNtOHhqQVhNV3pOMmlIU25LWW1hNFVJa3UzcDVOUUZDcHZEN0c0YWRaTzVTLVIzQ2J3TlRxRmsyTHlNOEM4N1pTUUFNa1R6OE5xcEQ1N3RWR1o3ZENZQWNOcmdnUG93MnJocVI1Yw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2025-08-07T07:00:00+00:00", "published_display": "07 Aug 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 97, "total_relevant": 63, "sentiment_summary": {"positive": 20, "negative": 5, "neutral": 38, "score": 56, "total": 63, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 80, "events": [{"event": "general", "label": "Market update", "weight": 19.6, "count": 35}, {"event": "earnings", "label": "Earnings", "weight": 8.94, "count": 19}, {"event": "analyst", "label": "Analyst action", "weight": 3.3, "count": 6}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 20, "negative_events": 5}, "market_context": {"has_market_context": true, "latest_close": 25.75, "latest_week": "2026-07-10", "one_week_move": 14.4, "four_week_move": 18.1, "twelve_week_move": -2.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.497016, "market_dynamics_buy_signal": false, "relative_strength": -12.735573, "fair_value_gap": -36.2, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 45.0081, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+14.4% over one week, +18.1% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 65, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 19}, {"label": "Stock Titan", "count": 6}, {"label": "TradingView", "count": 5}, {"label": "Investing.com", "count": 4}, {"label": "Simply Wall Street", "count": 4}, {"label": "StockStory", "count": 3}, {"label": "GlobeNewswire", "count": 2}, {"label": "Moomoo", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 52}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 35}, {"label": "Earnings", "count": 19}, {"label": "Analyst action", "count": 6}, {"label": "Deals and strategy", "count": 1}, {"label": "Regulatory and legal", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "56/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "80/100 classification confidence."}, {"label": "Company focus", "value": "52", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+14.4% over one week, +18.1% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Enovis Corp (ENOV) Shares Surge 3.8% -- What GF Score of 60 Tells Investors"}], "updated_at": "2026-07-16T05:41:39.441531+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}